Search results for "Essential"

showing 10 items of 812 documents

9.11 Association between Plasma Aldosterone, Metabolic Syndrome and Left Ventricular Mass in Essential Hypertension

2008

medicine.medical_specialtyAldosteronebusiness.industrymedicine.diseaseEssential hypertensionLeft ventricular masschemistry.chemical_compoundPharmacotherapychemistryInternal medicineInternal MedicineCardiologymedicineMetabolic syndromeCardiology and Cardiovascular MedicinebusinessHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Relationship Between Ambulatory Artery Stiffness Index and Glomerular Filtration Rate in Essential Hypertension

2007

medicine.medical_specialtyAmbulatory blood pressurePharmacotherapybusiness.industryInternal medicineInternal MedicinemedicineCardiologyambulatory artery stiffness index glomerular filtration rate essential hypertensionCardiology and Cardiovascular Medicinemedicine.diseasebusinessObesityHigh Blood Pressure & Cardiovascular Prevention
researchProduct

Blood Pressure Measurement Before and After Intervention

2016

The complexity and the uncertainties about long-term effect of the invasive interventions to treat essential hypertension (HTN) require a precise diagnosis about the real “resistance” to the antihypertensive treatment given, and it is defined when a therapeutic strategy that includes appropriate lifestyle measures plus a diuretic and two other antihypertensive drugs belonging to different classes at adequate doses fails to lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) values to <140 and 90 mmHg, respectively. Consequently, in the process of diagnosis and follow-up, blood pressure (BP) measurement is the first step that is not exempt of difficulties due to the variab…

medicine.medical_specialtyAmbulatory blood pressurebusiness.industrymedicine.medical_treatmentResistant hypertensionEssential hypertensionmedicine.diseaseBlood pressureIntervention (counseling)Internal medicineCardiologyMedicineDiureticbusinessPulse wave velocityTherapeutic strategy
researchProduct

Complémentarité et équilibre de l’apport alimentaire en protéines et en lipides

2003

The nature and level of dietary protein is liable to influence cholesterol and essential fatty acid (EFA) metabolism. Dietary vegetable protein, particularly the undigested fraction, decreases intestinal cholesterol absorption, increases the faecal excretion of steroids, and enhances the catabolism of cholesterol-carrying lipoproteins by increasing the activity or number of LDL receptors. However, the hypocholesterolemic effect of protein may be due to the presence of non-protein components and hence the purity degree of the selected protein, and the concomitant addition or not of cholesterol. Dietary proteins with different amino acid composition may modulate the secretion of hormones (e.g…

medicine.medical_specialtyAntioxidantmedicine.medical_treatmentlcsh:TP670-699soy proteinBiochemistrycaseinchemistry.chemical_compoundEssential fatty acidInternal medicinemedicineessential fatty acidchemistry.chemical_classificationCatabolismChemistryCholesterolcholesterolMetabolismprotein malnutritionperoxidationEndocrinologyLDL receptorIntestinal cholesterol absorptionlipids (amino acids peptides and proteins)lcsh:Oils fats and waxesFood SciencePolyunsaturated fatty acidOléagineux, Corps gras, Lipides
researchProduct

Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension.

1998

Angiotension converting enzyme (ACE) inhibitors and beta-blockers have been reported to possess disparate effects on insulin sensitivity. The aim of this study was to study the effects of the selective beta-1 blocker bisoprolol and of the ACE inhibitor captopril on cellular insulin action in hypertensive individuals. After washout, 12 mild to moderate essential hypertensives were randomized in a double-blind manner to 5 mg bisoprolol daily or 25 mg captopril twice daily for 8 weeks. Erythrocyte insulin binding and insulin-stimulated tyrosine kinase (TK) activity were measured before and after therapy. Both agents decreased diastolic blood pressure significantly (bisoprolol 96.5+/-0.9 to 87.…

medicine.medical_specialtyCaptoprilmedicine.medical_treatmentAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsEssential hypertensionInsulin resistanceDouble-Blind MethodInternal medicineInternal MedicinemedicineBisoprololHumansAgedbiologybusiness.industryInsulinCaptoprilAngiotensin-converting enzymeMiddle Agedmedicine.diseaseReceptor InsulinInsulin receptorEndocrinologyBisoprololACE inhibitorHypertensionbiology.proteinInsulin Resistancebusinessmedicine.drugAmerican journal of hypertension
researchProduct

The REDHY Study: Prevalence of Decreased Renal Function in Uncomplicated Essential Hypertension

2007

medicine.medical_specialtyDecreased renal functionPharmacotherapybusiness.industryInternal medicineInternal MedicinemedicineCardiologyCardiology and Cardiovascular MedicineEssential hypertensionmedicine.diseasebusinessHigh Blood Pressure &amp; Cardiovascular Prevention
researchProduct

ENDOTHELIAL DYSFUNCTION AND VITAMIN D STATUS IN ESSENTIAL HYPERTENSION. PRELIMARY RESULTS

2011

medicine.medical_specialtyEndocrinologyPhysiologybusiness.industryInternal medicineInternal MedicinemedicineVitamin D and neurologyEndothelial dysfunctionCardiology and Cardiovascular Medicinemedicine.diseasebusinessEssential hypertensionJournal of Hypertension
researchProduct

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL

2019

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET .

medicine.medical_specialtyEndotheliumGastroenterologySettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicinePolycythemia veraInternal medicineDiabetes mellitushemic and lymphatic diseasesmedicinePlateletEssential ThrombocythemiaPolycythemia VeraThrombotic riskEssential thrombocythemiabusiness.industrylcsh:RC633-647.5Hematologylcsh:Diseases of the blood and blood-forming organsmedicine.diseaseObesityPolycythemia vera Essential ThrombocytemiaInfectious Diseasesmedicine.anatomical_structure030220 oncology & carcinogenesisOriginal ArticlebusinessDyslipidemia030215 immunologyMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Adhesion molecules, endothelial products, and microalbuminuria in essential hypertension

2001

medicine.medical_specialtyEndotheliumbiologybusiness.industryCell adhesion moleculeIntercellular Adhesion Molecule-1Essential hypertensionmedicine.diseaseEndothelin 1medicine.anatomical_structureEndocrinologyInternal medicineE-selectinInternal Medicinemedicinebiology.proteinMicroalbuminuriaEndothelial dysfunctionbusinessAmerican Journal of Hypertension
researchProduct

Arterial Stiffness in Periodontal Disease

2007

medicine.medical_specialtyEndotheliumbusiness.industryEssential hypertensionmedicine.diseasemedicine.anatomical_structureInternal medicinemedicine.arteryInternal MedicinemedicineCardiologyBrachial arteryCardiology and Cardiovascular MedicineRecent onsetbusinessHigh Blood Pressure &amp; Cardiovascular Prevention
researchProduct